Historical record - last NADAC publication: 5/22/2024
Product Information
MEROPENEM IV 500 MG VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $2.8678 per EA under NDC 63323050721. Its NADAC has been published 57 times since Apr 17, 2024.
Strength
500 mg/10mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323050721
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
5/22/2024
Active Ingredients
MEROPENEMApproval Type
Generic (ANDA)
FDA Application
ANDA091404On Market Since
10/14/2011
Pharmacological Classes
Price Statistics
The NADAC for MEROPENEM IV 500 MG VIAL has been published 57 times since Apr 17, 2024, and over the history we have for it it has declined 23.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8678 per EA |
|---|---|
| All-time high | $3.7564 (May 15, 2024) |
| All-time low | $2.8678 (May 22, 2024) |
| Median price | $2.8678 |
| Average price | $2.9457 |
| Largest weekly change | -23.7% (May 22, 2024) |
| Weeks tracked | 57 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEROPENEM IV 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 500 MG VIAL, manufactured by Fresenius Kabi USA, LLC, is $2.8678 per EA (NDC 63323050721), effective May 14, 2025.
How has the price of MEROPENEM IV 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for MEROPENEM IV 500 MG VIAL has declined 23.7%. It has been tracked across 57 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MEROPENEM IV 500 MG VIAL?
Since Apr 17, 2024, the NADAC for MEROPENEM IV 500 MG VIAL has ranged from a low of $2.8678 (May 22, 2024) to a high of $3.7564 (May 15, 2024), with a median of $2.8678 per EA.
Are there cheaper alternatives to MEROPENEM IV 500 MG VIAL?
6 NADAC-published products share the same active ingredient, strength, and dosage form as MEROPENEM IV 500 MG VIAL, but none are currently priced below it.
Who manufactures MEROPENEM IV 500 MG VIAL?
MEROPENEM IV 500 MG VIAL (NDC 63323050721) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification